Amir Ahmadi
Cardiovascular Disease · New York, NY
CMS Profile ID: 1639559 · NPI: 1154778900
Total Disclosed General Payments
$665,511.84
General-payment records
39
CMS Program Year
2025
Most of this (more than 99%) was consulting fees.
Payments by Type
| Payment Type | Amount |
|---|---|
| Consulting Fee | $665,122.04 |
| Food and Beverage | $389.80 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Elucid Bioimaging Inc | $665,122.04 |
| Novartis Pharmaceuticals Corporation | $201.82 |
| SCPHARMACEUTICALS INC. | $102.37 |
| PFIZER INC. | $39.65 |
| E.R. Squibb & Sons, L.L.C. | $25.83 |
| AstraZeneca Pharmaceuticals LP | $20.13 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1154778900 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1154778900.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.